Centenaire Biosciences
Centenaire Biosciences is a biopharmaceutical company that develops new drugs for cancer, immune diseases, and brain nerve diseases.
Funding reportedLast round: Series A
What company datasets say Centenaire Biosciences raised
Funding, as reported
Reported in all20Bin the source's currency
Rounds1
Last roundSeries A
Last round dateMar 2022
Investors listed2
Biopharma in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Centenaire Biosciences in front of investors. Or tell us what we have wrong.